Alyeska Investment Group’s Mead Johnson Nutrition Company MJN Stock Holding History

Alyeska Investment Group’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-378,102	Closed	-$26.8M	–	602
2016 Q4	$26.8M	Buy	378,102 +311,324	+466%	+$23.2M	0.22%	161
2016 Q3	$5.28M	Buy	+66,778	New	+$5.7M	0.05%	317
2015 Q4	–	Sell	-51,738	Closed	-$3.64M	–	530
2015 Q3	$3.64M	Buy	+51,738	New	+$4.26M	0.04%	287
2015 Q2	–	Sell	-227,611	Closed	-$22.9M	–	623
2015 Q1	$22.9M	Buy	+227,611	New	+$23M	0.32%	125
2014 Q4	–	Sell	-158,536	Closed	-$15.3M	–	575
2014 Q3	$15.3M	Buy	158,536 +99,949	+171%	+$9.47M	0.31%	117
2014 Q2	$5.46M	Buy	+58,587	New	+$5.12M	0.12%	218
2013 Q4	–	Sell	-41,146	Closed	-$3.06M	–	420
2013 Q3	$3.06M	Buy	+41,146	New	+$3.08M	0.12%	186

Other funds holding MJN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alyeska Investment Group's MJN Position: Q1 2017 in Review

Alyeska Investment Group sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 378,102 shares — an estimated $26.8M sold.

Alyeska Investment Group first reported a position in MJN in Q3 2013 and held it in 7 quarters. The position peaked at $26.8M in Q4 2016. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

Alyeska Investment Group reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
Alyeska Investment Group sold 378,102 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $26.8M.
Alyeska Investment Group first reported a position in Mead Johnson Nutrition Company in Q3 2013 and held it in 7 quarters.
Alyeska Investment Group's Mead Johnson Nutrition Company position peaked at $26.8M in Q4 2016.
533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Alyeska Investment Group's 13F filing for Q1 2017, filed 15 May 2017.